BeStock  
Stocks › Biotechnology › VCEL

Vericel VCEL

US equityMarket cap rank #2449BiotechnologyCAR-T Therapy
$57.52 −$0.74 (-1.27%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $57.52 0.00%
Open$58.11
Prev close$58.26
Day range$57.33 – $59.49
Volume582.3K
Market cap$2.94B
P/E (TTM)89.9
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings89.0x
CheapRich

Around its usual level · 50th percentile, 5-year average 719.7x

#2794 of 2993 stocks by PE (1 = cheapest)

Price / book7.6x
CheapRich

Around its usual level · 47th percentile, 5-year average 7.9x

#4775 of 5330 stocks by PB (1 = cheapest)

Price / sales9.0x
CheapRich

Around its usual level · 53rd percentile, 5-year average 9.1x

#4425 of 5155 stocks by PS (1 = cheapest)

P/E over five years

-1,352x1,005x3,363x5,720xOct '21Apr '24Nov '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$53.59
Price vs. fair value+7.3%Trading above the estimate
Star rating★★★☆☆
Economic moatNarrow
UncertaintyMedium
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 7.57 – 7.91 47% (cheaper than usual) #4775 of 5330 (1 = cheapest)
PE 89.00 62.60 719.71 50% (pricier than usual) #2794 of 2993 (1 = cheapest)
PS 8.97 7.67 9.06 53% (pricier than usual) #4425 of 5155 (1 = cheapest)

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Discussion

No comments yet — be the first to weigh in on VCEL.

Sign in to join the discussion.

Scroll to Top